Ironwood Pharmaceuticals, Inc.
IRWD
$1.49
$0.0352.41%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.65M | -860.00K | -4.16M | -1.09M | 15.32M |
| Total Depreciation and Amortization | 907.00K | 106.00K | 513.00K | 512.00K | 507.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.97M | 22.81M | 15.06M | 44.95M | 21.38M |
| Change in Net Operating Assets | -10.63M | 11.41M | 33.58M | -8.55M | -4.75M |
| Cash from Operations | 9.89M | 33.47M | 44.99M | 35.83M | 32.46M |
| Capital Expenditure | -16.00K | -58.00K | -68.00K | -211.00K | -49.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -3.98M | -22.58M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.00K | -58.00K | -68.00K | -4.19M | -22.63M |
| Total Debt Issued | 0.00 | 150.00M | -- | 0.00 | 0.00 |
| Total Debt Repaid | -25.00M | -200.00M | -25.00M | -25.00M | -75.00M |
| Issuance of Common Stock | 0.00 | 749.00K | 10.06M | 998.00K | 12.00K |
| Repurchase of Common Stock | 0.00 | -121.00K | -616.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.16M | -- | -- | -26.90M | 0.00 |
| Cash from Financing | -27.16M | -49.37M | -15.56M | -50.90M | -74.99M |
| Foreign Exchange rate Adjustments | -26.00K | -51.00K | 24.00K | -50.00K | -3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.31M | -16.02M | 29.39M | -19.31M | -65.16M |
